Sun Pharmaceutical Industries has informed that it enclosed the Annual Disclosure for FY 2021-22, in Annexure -1, as required pursuant to clause 4.1 (ii) of SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, which, otherwise is applicable only to Large Corporate.
The above information is a part of company’s filings submitted to BSE.